Clinical trial
A Randomised, Double-blind, Placebo-controlled Parallel Group, Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis
NCT01562314 is registered in ClinicalTrials.gov with GW Research Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised, Double-blind, Placebo-controlled Parallel Group, Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis
- Lead sponsor
- GW Research Ltd
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 9, 2012
- Completion date
- August 5, 2014
- Enrollment
- 60 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
ulcerative colitis